Since the patent for Stelara (ustekinumab) expired in 2024, there are now four ustekinumab biosimilars available in the UK:PyzchivaSteqeymaUzpruvoWenzelaWe expect that the majority of the patients on BADBIR who are currently taking Stelara will switch to one of the...